Los agonistas del receptor GLP-1 actan principalmente estimulando la liberacin de insulina cuando los niveles de glucosa en sangre estn elevados y suprimiendo la secrecin de glucagn, lo que ayuda a controlar el azcar en sangre
Subgroup analyses (duration of trial, type of medication) and sensitivity analyses (secondary prevention, T2DM only) were conducted
TRULICITY is contraindicated in patients with a personal or family history of MTC and in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Indulge in the sumptuous sensation of our Strawberry Lip Balm enriched with a luminous Vitamin C serum
Many of them are in the middle of active GLP-1 treatment they have lost weight, experienced metabolic improvements, and are facing the prospect of their progress reversing if they cannot find an affordable continuation pathway before their current supply runs out
Role of phosphodiesterase-4 inhibitors in chronic obstructive pulmonary disease